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Early pregnancy sera were earlier shown to modulate T
lymphocyte rosetting with sheep erythrocytes. We set out to
investigate whether early pregnancy sera also modulate the
state of activation of another immunologically relevant cell
type, the monocyte. As an index of monocyte activation, we
measured phorbol ester-triggered oxidative burst activity by
a highly sensitive chemiluminescence method. Contrary to our
expectations, incubation of mononuclear cells with sera taken
early after embryo transfer from patients with a successfully
developing pregnancy had no effect. Unexpectedly, such sera
from patients from a control group of patients in whom no
pregnancy developed after embryo transfer caused enhance-
ment of mononuclear cell chemiluminescence. Stimulatory
activity of these sera appeared between days 4 and 6 and was
maximal between days 7 and 9 post embryo transfer. Whether
this phenomenon is causally related to, or represents a conse-
quence of the failure of embryo transfer, can currently not
be decided.
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Introduction
The concept of circulating serum factors indicative of the state
of a pre- or peri-implantation embryo (early pregnancy factor,
EPF) was originally developed by Morton et al. from their
finding of serum factors able to co-inhibit rosette formation
between T lymphocytes and sheep red blood cells (Morton et al.,
1976). Since this original observation, results reported from a
number of laboratories led to the conclusion that the signalling
systems between embryo and mother are complex in nature and
utilize a wide variety of mediators, some of which are also
involved in immune reactions. Thus, for example, O'Neill et al.
showed that in the mouse, successful fertilization is accompanied
by peripheral thrombocytopenia due to the release of a embryo-
derived platelet-activating factor (O'Neill et al., 1985). More
recently, the ovine trophoblast protein OTP-1 was shown to be
a member of the interferon super-family and indeed anti-luteolytic
activity of interferons can be demonstrated in some species
(Imakawa et al., 1987). These and other mediators appear to be
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largely or wholly involved in the control of luteal function. The
presence of large numbers of infiltrating leukocytes at the site
of implantation and the necessity for explaining the immuno-
logically privileged nature of the embryo suggest, however, that
the implanting embryo may modulate some component(s) of the
maternal immune system. In addition to the central role of T-
lymphocytes, accessory cells such as monocytes/macrophages
participate in the regulation of the immune response. We therefore
investigated whether monocyte activity is influenced by serum
obtained in early pregnancy, with the additional aim of developing
an alternative to the rosette inhibition test for early pregnancy
factor (EPF). Depending on their activation state, monocytes/
macrophages produce a great variety of biologically active
mediators, ranging from reactive oxygen species such as super-
oxide and lipid mediators such as prostaglandins to peptide
mediators, for example GM-CSF and IL-1. In the present study,
we investigated whether sera taken from patients early after
embryo transfer have the potential to modulate the activation state
of monocytes, using sera taken before embryo transfer as
controls. As an index of monocyte activity we measured
superoxide-dependent lucigenin-amplified chemiluminescence
(Allen etal, 1985).
Materials and methods
The study population comprised 13 patients in whom pregnancy
developed (ET+) after in-vitro fertilization and embryo transfer,
performed as described previously (Sterzik et al., 1988). Twelve
other patients, in whom no pregnancy developed after the same
procedure performed at the same institution and in the same time
period (ET-) , were also studied.
Sera from patients were collected before and within 18 days
after the procedure, sterile filtered and stored at —20°C until
assayed.
Mononuclear cells (MNC) were prepared from peripheral
blood of healthy male volunteers by Ficoll gradient centrifugation
(specific gravity of Ficoll = 1.077) and washed twice in Hank's
balanced salt solution without divalent cations. Finally, MNC
were suspended at a density of 5 x 106/ml in phenol red-free
minimal essential medium (T038, Biochrom/Seromed, Berlin,
FRG) buffered to pH 7.2 with 20 mM HEPES (Calbiochem, La
Jolla, USA) containing 100 /ig/ml of bovine serum albumin
(Behringwerke, Marburg, FRG) (T038/BSA). Flow-cytometric
determination of cellular composition of MNC was done on an
Ortho 50H cytofluorograph, using the following FITC-labelled
murine monoclonal antibodies (Becton Dickinson Monoclonal
Center, Mountain View, CA): anti-Leu 4 (T cells, CD3), anti-
Leu 12 (B cells, CD 19), anti-LeuM3 (monocytes/macrophages)
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and anti-Leu 11 (CD16 on natural killer cells and granulocytes).
The cellular composition of MNC from donor I (II) thus
determined was the following: 75(82)% T cells, 6(7)% B cells,
15(10)% monocytes, 5(4)% NK cells, < 1(< 1)% granulocytes.
Mononuclear cell incubation with patient sera was performed
as follows: 100 n\ aliquots of the MNC suspension (= 0.5 x
106 MNC) were dispensed in microtitre plate wells (Black
microtitre plates, Dynatech, Embrach-Embraport, Switzerland)
and incubated with 100 ;tl of patient serum for 60 min at 37°C.
Thereafter, serum was removed by three cycles of centrifugation,
aspiration of supernatant with a modified ELISA washer and
renewed addition of T038/BSA medium, yielding a final serum
concentration < 1 %. Control experiments showed that no cells
were lost by this procedure.
Measurement of chemiluminescence (CL) from samples
contained in microtitre plates was performed as follows. Cells
were stimulated with 20 ng/ml of phorbol myristyl acetate in the
presence of 100 /*M lucigenin (JV,N-dimethyl-acridinium nitrate;
both from Sigma, Miinchen, FRG). The 60 min integral of CL
was then measured using a computer-aided microtitre plate
luminometer as described in more detail elsewhere (Maly et al.,
1988). It was thus possible to complete the evaluation of all serum
samples in triplicates on MNC of one donor within <3 h.
Because sera from different individuals affected the CL of test
MNC differently, for each patient, the CL value obtained with
her serum taken on the transfer day was used as reference and
set at 100. Results obtained with the other sera from the individual
patient were expressed relative to this sample, yielding relative
CL values in per cent.
To further compare the time course of relative CL values
between the group of patients with successfully established
pregnancy (ET+) and those in whom no pregnancy developed
(ET —), the values of 3-day intervals before and after the day
of embryo transfer where grouped together and averaged. Though
this procedure diminished the temporal resolution of the study,
it was necessary because for technical reasons (outpatient
procedure) it was not possible to obtain a serum sample every
day from each patient.
Results and discussion
Post-transfer sera from the majority of ET — patients enhanced
the chemiluminescence response of male mononuclear cells to
PMA, while post-transfer sera of ET+ patients had only slight
stimulatory or inhibitory effects (Figure I). On average, this
stimulatory activity of ET — sera appeared between days 4 and
6, was maximal between days 7 and 9 post-transfer (maximal
value: 172 ± 32%, mean ± SEM, N = 9) and thereafter
returned to baseline levels. In contrast, the group of ET+ patients
showed on average no significant effects of post-transfer sera on
chemiluminescence of indicator MNC (Figure 2). Differences
between the relative CL means of E T - and ET+ groups were
statistically significant at days 4 to 6 and 7 to 9 (P = 0.0063
for days 4 - 6 and P = 0.065 for days 7 - 9 , Test 1, Student's
/-test). Interestingly, in six of eight individual E T - patients from
whom sera in the period between days 4 and 6 were available,
relative CL values greater than the mean +2 SD of the values
of the ET+ group in this time interval were found. As can also
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Fig. 1. Time course of MNC CL-modulating activity of individual
sera from ET+ (upper panel) and E T - patients (lower panel).
For each patient, MNC chemiluminescence values are expressed as
a percentage of the value obtained with her serum taken on or
shortly before the day of embryo transfer, denoted as day 0
(arrow) and are linked by solid lines. Data are means of triplicate
determinations with SD <20% of the respective mean (Test 1).
be seen from Figure 2, these findings could be reproduced with
target MNC from another donor.
The major cell type among blood mononuclear cells capable
of producing CL was the monocyte, though a few contaminating
granulocytes were present (<1%). This makes likely the
possibility that monocytes are the primary target cells of the
MNC-CL enhancing activity described (Babior, 1978). However,
it is also possible that the effect results from an interaction
between serum factors, monocytes and other cells present in
MNC, for example T lymphocytes or natural killer cells, which
may modulate the monocyte oxidative burst. Therefore,
participation of NADPH oxidase-negative cells, such as T or NK
cells, in the mechanism leading to the observed enhancement of
mononuclear cell oxidative activity is to be further investigated.
Several soluble mediators are known to enhance the superoxide-
forming capacity of monocytes/macrophages, e.g. the
lymphokines gamma-interferon and granulocyte-macrophage
colony stimulating factor. However, they are mainly produced
and consumed locally and generally not found in the circulation,
and it is therefore unlikely that they could be responsible for the
observed phenomenon. Further research is needed to examine
the nature of the factor(s) responsible for the upward modulation
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Fig. 2. Time course of mean MNC CL modulating serum activity.
MNC CL modulation values obtained with MNC from two
different donors (Test 1 and 2) were averaged over 3-day periods
as described in Materials and methods. The day of embryo transfer
is denoted day 0. Data shown are mean ± SEM. P values indicate
the significance of differences between ET+ and E T - .
of MNC CL.
We had originally expected that sera from patients developing
a pregnancy would exert inhibitory effects, in analogy with the
findings of Morton et al. (1976) concerning EPF. We chose the
phorbol ester PMA as trigger of the mononuclear cell oxidative
burst because it is one of the most potent activators of the
oxidative burst which also bypasses cell surface receptors and
activates cell functions more directly, typically via protein
kinase C. Therefore, effects on PMA-induced responses, like the
enhancement described, are likely to be caused at the post-
receptor level, e.g. within the protein kinase C-initiated signalling
pathway or at the level of the NADPH oxidase itself. From this,
it is probable that ET-sera will cause an enhancement of the MNC
oxidative burst also when PKC and NADPH oxidase are activated
via receptor-mediated mechanisms such as phagocytosis, though
this will have to be tested experimentally.
Earlier, changes in the rosette-inhibitory activity of early
pregnancy sera were reported which correlated with the outcome
of mating or embryo transfer (early pregnancy factor; Morton
et al., 1976). The finding that no differences in the MNC-CL
modulatory activity of pre- and post-transfer sera of patients who
developed a pregnancy were detected suggests that early
pregnancy factor does not modulate monocyte oxidative burst,
at least not in the amounts present in such sera. However, the
finding of serum factors enhancing the monocyte oxidative burst
in the group of patients in whom embryo transfer was not
followed by establishment of pregnancy—originally devised as
the control group—was unexpected and merits further
investigation. The time at which these serum effects were noted
would qualify them as associated with the late preimplantation
or the peri-implantation period.
Elevated oestradiol levels and hence increased oestradiol/pro-
gesterone levels have been found to be associated with failed IVF
attempts. However, no difference in oestradiol/progesterone
ratios was evident between the ET+ and ET— patient groups
investigated in this study (data not shown). In addition, oestradiol
and progesterone have been demonstrated to inhibit the
superoxide-generating NADPH oxidase in vitro (Buyon et al.,
1984). It is therefore unlikely that either of them could, alone,
be responsible for the observed enhancement of superoxide
generation.
In summary, the phenomenon we describe in this communica-
tion could be connected with the process itself which causes loss
of the embryo. Thus, our data could be interpreted as further
evidence for the existence of peripherally detectable parameters
reflecting the fate of the embryo. Alternatively, the upward
modulation of MNC CL in the patients that did not become
pregnant, might merely be a consequence of the failure of
pregnancy, such as, for instance, resolution of the corpus luteum.
A study with serum samples taken throughout the menstrual cycle
of normal women not attempting to conceive and taking no
contraceptive medication could provide pertinent information; but
due to obvious difficulties in obtaining such serum samples, these
data are not yet available. Though it is therefore presently not
possible to conclude which interpretation is correct, our data show
that failure of an embryo to establish a pregnancy is associated
with peripherally detectable factors effecting changes in immune
cell function.
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